Current developments and future directions in COPD

Alexander G. Mathioudakis, Lowie E.G.W. Vanfleteren, Lies Lahousse, Andrew Higham, James P. Allinson, Carolina Gotera, Dina Visca, Dave Singh, Antonio Spanevello

Source: Eur Respir Rev, 29 (158) 200289; 10.1183/16000617.0289-2020
Journal Issue: December
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Alexander G. Mathioudakis, Lowie E.G.W. Vanfleteren, Lies Lahousse, Andrew Higham, James P. Allinson, Carolina Gotera, Dina Visca, Dave Singh, Antonio Spanevello. Current developments and future directions in COPD. Eur Respir Rev, 29 (158) 200289; 10.1183/16000617.0289-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Current developments and future directions in respiratory physiotherapy
Source: Eur Respir Rev, 29 (158) 200264; 10.1183/16000617.0264-2020
Year: 2020



Introduction: CPET in clinical practice. Recent advances, current challenges and future directions
Source: Eur Respir Monogr 2018; 80: x-xxv
Year: 2018

Therapeutic management - Current status and future developments
Source: COVID-19 Videos
Year: 2020

Clinical implications – potential future developments in EBC research
Source: Annual Congress 2007 - ERS/ATS joint symposium: the report of the ERS/ATS Task Force on Exhaled Breath Condensate
Year: 2007


COPD – future prospects for women
Source: Eur Respir J 2006; 28: Suppl. 50, 447s
Year: 2006

The pharmacoepidemiology of COPD: Recent advances and methodological discussion
Source: Eur Respir J 2003; 22: 1S-44S
Year: 2003


Summary and future developments
Source: Eur Respir Monogr 2010; 49: 247-249
Year: 2010

Controversies in OSA: causes and future directions
Source: Virtual Congress 2021 – What is new for sleep apnoea? The European perspective: findings from the European Sleep Apnoea Database (ESADA)
Year: 2021


Assessing the worldwide epidemiology of sarcoidosis: challenges and future directions
Source: Eur Respir J 2016; 48: 1545-1548
Year: 2016


Challenges in COPD exacerbations and future research and unknowns
Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention
Year: 2013

COPD - Current challenges
Source: Research Seminar 2009 - Post Genome Respiratory Epidemiology II - An interdisciplinary challenge
Year: 2008


What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement
Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018
Year: 2018



Future developments in IPF biomarkers
Source: ERS Course 2016
Year: 2016



Recommendations of new therapies for severe asthma and the future
Source: Annual Congress 2013 –ERS/ATS Task Force report on severe asthma
Year: 2013


Treatment of interstitial lung diseases: current approaches and future directions
Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options
Year: 2021


Future directions: preventing and treating asthma
Source: International Congress 2016 – Childhood wheeze: are we making any progress?
Year: 2016


Monitoring asthma in children: conclusions and future directions
Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force
Year: 2014



Ongoing and future initiatives of WHO in the field of respiratory research
Source: Annual Congress 2004 - European and other initiatives in the field of respiratory health and the environment
Year: 2004